Cell Death and Disease · 2019 · 128 citations · 16 references
MedicineOncologyPharmacologyCancer PharmacologyGene ExpressionMolecular OncologyCancer Cell SignalingLung CancerNoncoding Rna In CancerOncogenic Signaling PathwaysSignal Transduction In CancerTumor Suppressor GenesCancer-related Noncoding Rna FunctionFunctional AssaysMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna-mediated ResistanceNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment
In this study, we identified a novel circRNA, circ_0002483, and further investigated its functions in the progression and Taxol resistance of NSCLC. We found that circ_0002483 was expressed at low levels in NSCLC tissues and cell lines. Functional assays indicated that circ_0002483 overexpression significantly inhibited NSCLC cell proliferation and invasion in vitro and in vivo and enhanced the sensitivity of NSCLC cells to Taxol. Mechanistically, circ_0002483 was identified to sponge multiple miRNAs including miR-182-5p (also named miR-182), miR-520q-3p, miR-582-3p, miR-587, and miR-655. In addition, circ_0002483 was also demonstrated to regulate the expression of GRB2, FOXO1, and FOXO3, three target genes of miR-182-5p, by sponging miR-182-5p. Circ_0002483 was demonstrated to inhibit NSCLC progression in vitro and in vivo and enhanced the sensitivity of NSCLC cells to Taxol by sponging miR-182-5p to release the inhibition on GRB2, FOXO1, and FOXO3 mRNAs.
16
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
Peter Goldstraw, Kari Chansky, John Crowley et al. · Journal of Thoracic Oncology · 2016 · 4.6K citations · Full text
How Taxol/paclitaxel kills cancer cells
Beth A. Weaver · Molecular Biology of the Cell · 2014 · 1.6K citations
Medicine, Oncology, Pharmacology +13